DIVIS LABORATORIES
Back to Cashflow Statement
|
DIVIS LABORATORIES Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹2,738 Cr | ₹1,653 Cr | ₹1,261 Cr | ₹2,459 Cr | ₹1,912 Cr |
What is the latest Cash Flow from Operating Activities ratio of DIVIS LABORATORIES ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2026 | ₹2,738 Cr |
| Mar2025 | ₹1,653 Cr |
| Mar2024 | ₹1,261 Cr |
| Mar2023 | ₹2,459 Cr |
| Mar2022 | ₹1,912 Cr |
How is Cash Flow from Operating Activities of DIVIS LABORATORIES Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹2,738 Cr | 65.64 | |
| Mar2025 | ₹1,653 Cr | 31.09 | |
| Mar2024 | ₹1,261 Cr | -48.72 | |
| Mar2023 | ₹2,459 Cr | 28.62 | |
| Mar2022 | ₹1,912 Cr | - | |
Compare Cash Flow from Operating Activities of peers of DIVIS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DIVIS LABORATORIES | ₹251,561.3 Cr | 2% | 5.3% | 57.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹446,276.0 Cr | -0.2% | -3.2% | 12.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹186,957.0 Cr | -2.4% | -3.1% | 36.4% | Stock Analytics | |
| CIPLA | ₹111,729.0 Cr | 0.6% | -2.2% | -9.4% | Stock Analytics | |
| MANKIND PHARMA | ₹105,120.0 Cr | -1.6% | 0.9% | -4.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹104,335.0 Cr | 0.9% | 4% | -7.6% | Stock Analytics | |
DIVIS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DIVIS LABORATORIES | 2% |
5.3% |
57.7% |
| SENSEX | -2.7% |
-5.7% |
-11.7% |
You may also like the below Video Courses